Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60

NCT02806804 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

2400

Enrollment

OTHER

Sponsor class

Conditions

Quadrivalent Influenza Virus Vaccine

Interventions

BIOLOGICAL: one dose test vaccine
BIOLOGICAL: one dose commercially available trivalent influenza vaccine
BIOLOGICAL: One dose of Quadrivalent Influenza Virus Vaccine

Sponsor

Beijing Chaoyang District Centre for Disease Control and Prevention